Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.
Authors: Sharma S; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Lin P; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Hu A; Cumberland Valley Retina PC, Hagerstown, Maryland., Suhler EB; Casey Eye Institute and VA Portland Health Care System, Portland, Oregon., Pauly-Evers M; Roche Pharma Research and Early Development, Basel, Switzerland., Holmes W; Roche Products Ltd, Welwyn Garden City, United Kingdom., Barekati Z; Roche Pharma Research and Early Development, Basel, Switzerland., Willen D; Roche Pharma Research and Early Development, Basel, Switzerland., Macgregor L; F. Hoffmann-La Roche AG, Basel, Switzerland., Steeples L; Roche Products Ltd, Welwyn Garden City, United Kingdom., Haskova Z; Genentech, Inc, South San Francisco, California., Feenstra D; Roche Pharma Research and Early Development, Basel, Switzerland., Silverman D; Roche Products Ltd, Welwyn Garden City, United Kingdom., Passemard B; Roche Pharma Research and Early Development, Basel, Switzerland., Fauser S; Roche Pharma Research and Early Development, Basel, Switzerland., Mesquida M; Roche Pharma Research and Early Development, Basel, Switzerland.; F. Hoffmann-La Roche AG, Basel, Switzerland.
Source: JAMA ophthalmology [JAMA Ophthalmol] 2026 May 01; Vol. 144 (5), pp. 442-451.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase I
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6173
DOI:10.1001/jamaophthalmol.2026.0610